Cargando…
Reply to ‘Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma’
Autores principales: | Jacquelot, Nicolas, Zitvogel, Laurence, Eggermont, Alexander M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6062500/ https://www.ncbi.nlm.nih.gov/pubmed/30050125 http://dx.doi.org/10.1038/s41467-018-05048-0 |
Ejemplares similares
-
Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma
por: Brochez, Lieve, et al.
Publicado: (2018) -
PD-Loma: a cancer entity with a shared sensitivity to the PD-1/PD-L1 pathway blockade
por: Hirsch, Laure, et al.
Publicado: (2018) -
Targeting PD-1/PD-L1 interactions for cancer immunotherapy
por: Zitvogel, Laurence, et al.
Publicado: (2012) -
Targeting Chemokines and Chemokine Receptors in Melanoma and Other Cancers
por: Jacquelot, Nicolas, et al.
Publicado: (2018) -
Microbiota-associated immunotherapy resistance caused by deficient PD-L2 - RGMb signaling
por: Fidelle, Marine, et al.
Publicado: (2023)